Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiscoverIE Regulatory News (DSCV)

Share Price Information for DiscoverIE (DSCV)

Share Price is delayed by 15 minutes
Get Live Data
678.00    -7.00 (-1.02%)
Bid:
665.00
Ask:
678.00
Spread: 13.00 (1.955%)
Market Cap: £658.48m
DSCV Live PriceLast checked at - London Stock Exchange

Intraday DiscoverIE Share Chart

Circular Posted

30 Oct 2009 07:00

RNS Number : 6495B
Acal PLC
30 October 2009
 



FOR RELEASE AT 7.00 AM

30 October 2009

ACAL PLC ("ACAL") 

PROPOSED ACQUISITION OF FINANCIÈRE BFI OPTILAS S.A.S. ("BFi OPTiLAS")

POSTING OF SHAREHOLDER CIRCULAR

Further to yesterday's announcement regarding Acal's proposed acquisition of the entire issued share capital of BFi OPTiLAS (the "Acquisition"), Acal posted to its shareholders on 29 October 2009 a circular (the "Circular") describing proposals for the Acquisition.

The Circular contains a notice of a general meeting of the Company to be held at 11 am on Thursday 19 November 2009 at 2 Chancellor Court, Occam Road, Surrey Research Park, Guildford GU2 7AH (the "General Meeting"),at which Acal's shareholders will vote on the Acquisition. Forms of Proxy for use at the General Meeting have also been sent to shareholders.

Copies of the Circular are available for inspection during normal business hours on any weekday (Saturdays, Sundays and public holidays excepted) at both the office of Lovells LLP, Atlantic House, Holborn Viaduct, London EC1A 2FG and the Company's registered office from the date of this announcement up to and including the date of the General Meeting.

In addition, a copy of the Circular has been submitted to the UKLA and will shortly be available for inspection at the UKLA's document viewing facility, which is situated at 25 The North Colonnade, Canary Wharf, London E14 5HS.

For further information, please contact:

Enquiries

Acal plc:

Nick Jefferies ~ Chief Executive  01483 544 500

Malcolm Cooper ~ Finance Director  01483 544 500

J.P. Morgan Cazenove Limited:

Patrick Magee ~ Managing Director 020 7155 4525

Salma Butt ~ Associate  020 7155 4852

Cubitt Consulting:

Brian Coleman-Smith 020 7367 5100

James Verstringhe 020 7367 5100

Nicola Krafft 07802 724 400

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQFDLSMSSUSEFS
Date   Source Headline
5th Sep 20232:17 pmRNSNotification of Major Holdings
31st Aug 20237:00 amRNSAcquisition completion - Silvertel
1st Aug 20237:00 amRNSAcquisition of Silvertel
24th Jul 20232:31 pmRNSResults of Annual General Meeting
24th Jul 20237:00 amRNSTrading Update
27th Jun 202310:53 amRNSDirector / PDMR Shareholding
27th Jun 202310:47 amRNSNotification of Major Holdings
22nd Jun 202312:35 pmRNSAnnual Report & Notice of AGM
19th Jun 20238:35 amRNSNotification of Major Holdings
15th Jun 20239:51 amRNSDirector LTIP Award
7th Jun 20237:00 amRNSPreliminary results
1st Jun 20232:50 pmRNSNotification of Major Holdings
30th May 20237:00 amRNSAppointment of Non-Executive Director
18th May 20231:33 pmRNSNotification of Major Holdings
17th May 202310:25 amRNSNotice of Full Year Results
19th Apr 20237:00 amRNSFull Year Trading Update
18th Apr 20237:00 amRNSNotification of Major Holdings
29th Mar 20235:47 pmRNSNotification of Major Holdings
15th Mar 20233:53 pmRNSNotification of Major Holdings
15th Mar 20238:37 amRNSNotification of Major Holdings
15th Mar 20237:00 amRNSNotification of Major Holdings
23rd Feb 20232:58 pmRNSNotification of Major Holdings
20th Feb 20239:48 amRNSNotification of Major Holdings
15th Feb 20235:33 pmRNSNotification of Major Holdings
13th Feb 202311:36 amRNSNotification of Major Holdings
25th Jan 20237:00 amRNSQ3 Trading Update and Acquisition Completion
6th Jan 20231:41 pmRNSNotification of Major Holdings
6th Jan 20238:24 amRNSNotification of Major Holdings
3rd Jan 202310:38 amRNSNotification of Major Holdings
22nd Dec 20227:00 amRNSAcquisition of Magnasphere Corporation
14th Dec 20224:31 pmEQSParadigm Biopharmaceuticals (PAR): Adapted therapies to meet unmet demand
5th Dec 20229:53 amEQSdiscoverIE Group (DSCV): Focused on sustainable growth
2nd Dec 202212:58 pmRNSNotification of Major Holdings
2nd Dec 20228:37 amRNSNotification of Major Holdings
23rd Nov 202212:01 pmEQSdiscoverIE Group profits jump in 'very strong first half'
23rd Nov 20227:00 amRNSdiscoverIE Commits to Net Zero Emissions
23rd Nov 20227:00 amRNSInterim Results
21st Nov 20223:38 pmRNSNotification of Major Holdings
16th Nov 20228:58 amRNSTR-1: Notification of Major Holdings
14th Nov 20223:41 pmRNSIssue of Equity & Total Voting Rights
1st Nov 202212:08 pmRNSNotice of Half Year Results
1st Nov 20227:00 amRNSDirectorate Changes
14th Oct 20224:56 pmRNSNotification of Major Holdings
13th Oct 20223:31 pmRNSTR-1: Notification of major holdings
13th Oct 20227:00 amRNSFirst Half Trading Update
11th Oct 202211:42 amRNSNotification of Major Holdings
5th Oct 20227:52 amRNSNotification of Major Holdings
5th Oct 20227:52 amRNSNotification of Major Holdings
28th Sep 20227:36 amRNSDirector Declaration
2nd Sep 202210:26 amRNSNotification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.